Advances in Precision Medicine Oncology

Recent advances in precision medicine and immuno-oncology have led to highly specific and efficacious cancer therapies such as monoclonal antibodies and immune checkpoint inhibitors (ICIs). This book provides an up-to-date overview of advances in the field of immuno-oncology. Chapters cover such top...

Full description

Saved in:
Bibliographic Details
Other Authors: Arnouk, Hilal (Editor), Abdul Rasool Hassan, Bassam (Editor)
Format: Electronic Book Chapter
Language:English
Published: IntechOpen 2021
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_131078
005 20231201
003 oapen
006 m o d
007 cr|mn|---annan
008 20231201s2021 xx |||||o ||| 0|eng d
020 |a intechopen.91507 
020 |a 9781839688683 
020 |a 9781839688676 
020 |a 9781839688690 
040 |a oapen  |c oapen 
024 7 |a 10.5772/intechopen.91507  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a MJCL  |2 bicssc 
100 1 |a Arnouk, Hilal  |4 edt 
700 1 |a Abdul Rasool Hassan, Bassam  |4 edt 
700 1 |a Arnouk, Hilal  |4 oth 
700 1 |a Abdul Rasool Hassan, Bassam  |4 oth 
245 1 0 |a Advances in Precision Medicine Oncology 
260 |b IntechOpen  |c 2021 
300 |a 1 electronic resource (260 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Recent advances in precision medicine and immuno-oncology have led to highly specific and efficacious cancer therapies such as monoclonal antibodies and immune checkpoint inhibitors (ICIs). This book provides an up-to-date overview of advances in the field of immuno-oncology. Chapters cover such topics as ICIs and how they mount a robust immune response against cancer cells as well as the response of ICIs to treatment predictive biomarkers and their potential immune-related adverse events (irAEs). Additionally, the book includes a comprehensive review of the powerful FDA-approved therapeutic agent doxorubicin, highlighting the molecular mechanisms behind doxorubicin's drug resistance and critical side effects. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/3.0/  |2 cc  |4 https://creativecommons.org/licenses/by/3.0/ 
546 |a English 
650 7 |a Oncology  |2 bicssc 
653 |a immunotherapy, doxorubicin, cancer immunotherapy, cancer, optimization, nanoparticles 
856 4 0 |a www.oapen.org  |u https://mts.intechopen.com/storage/books/10321/authors_book/authors_book.pdf  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/131078  |7 0  |z DOAB: description of the publication